Esin Izat

Esin Izat is a manager at Beghou Consulting

Articles

To Reduce Commercial Risk for Orphan Drugs, Transform Forecasting

To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.

Post-Launch Birthday: The Time to Refine

Following a new product’s first year on the market, there are four key ways companies can refine commercial strategies to maximize product sales.